Skip to content
Back to search results

EQ-5D

Introduced by
EuroQol Group
Year
1990
Type
Generic preference-based health utility measure
Family
Health-related quality of life
Font size

What does it do?

The EQ-5D is a standardized, preference-based health utility measure developed by the EuroQol Group in 1990.

It combines a descriptive health profile (five dimensions, three or five response levels) with a visual analog scale to quantify overall health status. The instrument has become essential for health economics, clinical trials, and cost-effectiveness analysis worldwide.

The intuition behind the method

The EQ-5D measures health status across five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Unlike descriptive instruments that itemize health aspects, the EQ-5D uses a unique preference-weighting system to generate a single index score (health utility) ranging from 0 (equivalent to death) to 1 (perfect health). This utility score directly enables cost-effectiveness analysis and budget impact modeling, making it invaluable for healthcare decision-makers and health economists.

History

The EQ-5D was developed by the EuroQol Group, a non-profit research collaboration, and first published in 1990. It was designed to provide a simple, generic health utility measure suitable for economic evaluation across diverse health conditions. The original EQ-5D-3L became widely adopted in health technology assessment worldwide. The EQ-5D-5L was introduced in 2011 to address ceiling effects and improve discriminatory power. The EuroQol Group maintains the instrument and regularly updates preference weights as new population surveys are conducted.

When to use it

The EQ-5D is the standard instrument for economic evaluation in health technology assessment (HTA), reimbursement decisions, and clinical trials requiring cost-effectiveness data. It is appropriate for adult populations across all health conditions and is less suitable for very young children (age < 4) or patients unable to self-report. Use condition-specific preference measures when condition-specific sensitivity is critical.

Limitations and considerations

  • The five dimensions may not capture all relevant health concepts; condition-specific measures often provide greater sensitivity
  • Preference weights are population-dependent; using one country's weights in another population introduces bias
  • EQ-5D-3L has ceiling effects (many respondents at '11111', perfect health); EQ-5D-5L addresses this but has less extensive validation
  • VAS is subjective and subject to anchoring effects; less reliable than utility index for ranking health states

Source conditions do not replace independent scientific review or validation by an analysis engine.

Strengths

  • Preference-weighted scoring enables direct health economic analysis and QALY calculations without additional instruments
  • Brief administration (1–2 minutes) allows use in large trials and population surveys
  • Extensive cross-country validation with standardized preference weights available for 50+ countries and regions
  • Simple five-dimension structure makes results intuitive and interpretable to patients and clinicians
  • Widely accepted by health technology assessment bodies and insurance regulators for reimbursement decisions

Applications

  • Health technology assessment: UK NICE, German AMWV, Australian PBAC use EQ-5D in reimbursement recommendations
  • Cost-effectiveness research: comparing QALYs across diverse interventions (drugs, surgeries, devices, behavioral programs)
  • Clinical trial outcomes: measuring health-related quality of life in pharmaceutical trials and device evaluations
  • Budget impact modeling: estimating healthcare spending changes from new treatments in health systems
  • Population health surveillance: tracking health utility across demographics in national health surveys

How it works

How it works

1

The EQ-5D exists in two versions: the EQ-5D-3L (original, three-level responses: no problem, some/moderate problem, severe problem) and EQ-5D-5L (newer, five-level responses: no problem, slight, moderate, severe, extreme). Administration takes 1–2 minutes. The questionnaire includes five items (one per dimension) plus a vertical Visual Analog Scale (VAS, 0–100) where respondents rate overall health.

2

The five dimension responses are converted to a single index score (health utility) using country-specific preference weights derived from general population surveys. Index scores typically range from values below 0 (worse than death) to 1.0 (perfect health), though some countries allow negative values. The VAS provides a second measure of overall health perception (0–100 scale). Both are used in health economic evaluations.

3

The EQ-5D index score quantifies health utility: 1.0 = perfect health, 0.5 = moderate health burden, 0.0 = equivalent to death, negative values = worse than death. The VAS complements the index with patient perception. In cost-effectiveness research, quality-adjusted life years (QALYs) are calculated by multiplying EQ-5D utility scores by years of life, enabling comparison of diverse interventions.

Common pitfalls

  • Using US population preferences for EQ-5D scoring in non-US countries without country-specific weights; preference structures differ substantially across regions
  • Comparing EQ-5D-3L and EQ-5D-5L scores directly without conversion; they use different reference populations and cannot be pooled
  • Interpreting the VAS as a utility measure or comparing it directly to the preference-weighted index; the two measure different constructs
  • Assuming EQ-5D is sensitive to small changes within a single condition; it performs best in detecting large shifts in health status

Frequently asked questions

What is the difference between EQ-5D-3L and EQ-5D-5L?

EQ-5D-3L has three response levels per dimension (no problem, some, severe); EQ-5D-5L has five (no, slight, moderate, severe, extreme). The 5L version is more sensitive to subtle health changes and reduces ceiling effects. However, 3L has more extensive international validation and longer history. Choose 5L for new studies; use 3L when comparing to historical data.

Why are EQ-5D preference weights country-specific?

Preference weights reflect how a country's general population values different health states. A British preference set may weight pain differently than a Spanish one due to cultural, healthcare, and language differences. Using incorrect country weights introduces systematic bias in cost-effectiveness conclusions and reimbursement decisions.

How is a QALY calculated from EQ-5D?

QALYs = EQ-5D utility score × time period in years. If a patient has an EQ-5D of 0.8 for one year, that is 0.8 QALYs gained. In cost-effectiveness research, cost per QALY gained is calculated to compare treatment options; thresholds like £20,000–30,000 per QALY guide reimbursement decisions in the UK.

Can negative EQ-5D scores occur, and what do they mean?

Yes; some health states are valued by society as worse than death, yielding negative utility scores. For example, some severe disease combinations might score -0.15. This reflects societal preference judgments and is used in economic models, though it can be conceptually challenging.

Related methods

Sources

  1. Rabin, R., & de Charro, F. (2001). EQ-5D: a measure of health status from the EuroQol Group. Annals of Medicine, 33(5), 337–343.

    Open DOI reference
    Copied.
  2. EuroQol Group. (1990). EuroQol—a new facility for the measurement of health-related quality of life. Health Policy, 16(3), 199–208.

    Open publication reference
    Copied.
  3. Herdman, M., Gudex, C., Lloyd, A., et al. (2011). Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Quality of Life Research, 20(10), 1727–1736.

    Open DOI reference
    Copied.